Hibiscus BioVentures
Overview
Hibiscus BioVentures is a venture capital firm and startup studio founded in 2019 and based in Rockville, Maryland. The firm is dedicated to advancing patient care by building and investing in companies focused on transformative technologies and commercially viable therapies in the biotechnology and pharmaceutical sectors. Hibiscus BioVentures operates through two distinct arms: Hibiscus Biotechnology (HBT), LLC, a venture studio that builds companies from the ground up, and Hibiscus Capital Management (HCM), LLC, a venture capital firm that invests in early-stage biotechnology companies. The firm's investment portfolio includes companies in life sciences, often at the Series A stage.
Portfolio Companies
3
Website
hibiscusbio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AsclepiX Therapeutics | Jul 2023 | Series A Extension | Co-investor |
| Cellevolve Bio | Nov 2021 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.